Joseph E. Gilliam

CIK: 0001705850

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (26.1%)

Position reduction

Option Exercises (M)9 (19.6%)

Derivative conversions

Awards (A)10 (21.7%)

Compensation grants

Other (G, F, J, C, D, …)15 (32.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CAI

Caris Life Sciences, Inc.

Director

GKOS

GLAUKOS Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (46 total)

CAI
Caris Life Sciences, Inc.
Aug 14, 2026
Award(A)
Direct
13.2K shares-
GKOS
GLAUKOS Corp
Aug 11, 2026
Sale(S)
Direct
32K shares at avg. $180.49$5.8M
GKOS
GLAUKOS Corp
Aug 11, 2026
Sale(S)
Direct
28K shares at avg. $178.89$5.0M
GKOS
GLAUKOS Corp
Aug 11, 2026
Exercise(M)
Direct
10K shares at avg. $48.46$485K
GKOS
GLAUKOS Corp
Aug 11, 2026
Exercise(M)
Direct
10K shares at avg. $48.46$485K
GKOS
GLAUKOS Corp
Aug 11, 2026
Exercise(M)
Direct
20K shares at avg. $55.18$1.1M
GKOS
GLAUKOS Corp
Aug 11, 2026
Exercise(M)
Direct
20K shares at avg. $55.18$1.1M
GKOS
GLAUKOS Corp
Jun 25, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $142.57$151K
GKOS
GLAUKOS Corp
May 1, 2026
Sale(S)
Direct
19.6K shares at avg. $143.54$2.8M
GKOS
GLAUKOS Corp
Apr 2, 2026
Tax Payment(F)
Direct
3.2K shares at avg. $109.60$347K
GKOS
GLAUKOS Corp
Mar 25, 2026
Award(A)
Direct
5.8K shares-
GKOS
GLAUKOS Corp
Mar 25, 2026
Award(A)
Direct
17.8K shares-
GKOS
GLAUKOS Corp
Mar 24, 2026
Tax Payment(F)
Direct
4.9K shares at avg. $105.23$518K
GKOS
GLAUKOS Corp
Mar 24, 2026
Tax Payment(F)
Direct
7.4K shares at avg. $105.23$777K
GKOS
GLAUKOS Corp
Mar 23, 2026
Tax Payment(F)
Direct
2.8K shares at avg. $106.84$300K
GKOS
GLAUKOS Corp
Mar 16, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $98.94$118K
GKOS
GLAUKOS Corp
Mar 13, 2026
Tax Payment(F)
Direct
2.5K shares at avg. $97.02$239K
GKOS
GLAUKOS Corp
Feb 24, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $119.17$126K
GKOS
GLAUKOS Corp
Jan 22, 2026
Sale(S)
Direct
3.2K shares at avg. $129.28$413K
GKOS
GLAUKOS Corp
Jan 22, 2026
Exercise(M)
Direct
10.5K shares at avg. $55.18$579K
GKOS
GLAUKOS Corp
Jan 22, 2026
Sale(S)
Direct
2.4K shares at avg. $126.10$303K
GKOS
GLAUKOS Corp
Jan 22, 2026
Sale(S)
Direct
3.1K shares at avg. $127.03$394K
GKOS
GLAUKOS Corp
Jan 22, 2026
Sale(S)
Direct
1.8K shares at avg. $128.07$230K
GKOS
GLAUKOS Corp
Jan 21, 2026
Sale(S)
Direct
4.5K shares at avg. $124.65$561K
GKOS
GLAUKOS Corp
Jan 21, 2026
Exercise(M)
Direct
4.5K shares at avg. $55.18$248K

		Type	Shares	Price		Ownership
Aug 14, 2026	CAI Caris Life Sciences, Inc.	Award(A)	13,192	-	$0	Direct
Aug 11, 2026	GKOS GLAUKOS Corp	Sale(S)	32,037	$180.49	$5,782,358	Direct
Aug 11, 2026	GKOS GLAUKOS Corp	Sale(S)	27,963	$178.89	$5,002,301	Direct
Aug 11, 2026	GKOS GLAUKOS Corp	Exercise(M)	10,000	$48.46	$484,600	Direct
Aug 11, 2026	GKOS GLAUKOS Corp	Exercise(M)	10,000	$48.46	$484,600	Direct
Aug 11, 2026	GKOS GLAUKOS Corp	Exercise(M)	20,000	$55.18	$1,103,600	Direct
Aug 11, 2026	GKOS GLAUKOS Corp	Exercise(M)	20,000	$55.18	$1,103,600	Direct
Jun 25, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	1,056	$142.57	$150,554	Direct
May 1, 2026	GKOS GLAUKOS Corp	Sale(S)	19,573	$143.54	$2,809,508	Direct
Apr 2, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	3,169	$109.60	$347,322	Direct
Mar 25, 2026	GKOS GLAUKOS Corp	Award(A)	5,829	-	$0	Direct
Mar 25, 2026	GKOS GLAUKOS Corp	Award(A)	17,792	-	$0	Direct
Mar 24, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	4,926	$105.23	$518,363	Direct
Mar 24, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	7,388	$105.23	$777,439	Direct
Mar 23, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	2,804	$106.84	$299,579	Direct
Mar 16, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	1,189	$98.94	$117,640	Direct
Mar 13, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	2,462	$97.02	$238,863	Direct
Feb 24, 2026	GKOS GLAUKOS Corp	Tax Payment(F)	1,057	$119.17	$125,963	Direct
Jan 22, 2026	GKOS GLAUKOS Corp	Sale(S)	3,194	$129.28	$412,920	Direct
Jan 22, 2026	GKOS GLAUKOS Corp	Exercise(M)	10,498	$55.18	$579,280	Direct
Jan 22, 2026	GKOS GLAUKOS Corp	Sale(S)	2,406	$126.10	$303,397	Direct
Jan 22, 2026	GKOS GLAUKOS Corp	Sale(S)	3,100	$127.03	$393,793	Direct
Jan 22, 2026	GKOS GLAUKOS Corp	Sale(S)	1,798	$128.07	$230,270	Direct
Jan 21, 2026	GKOS GLAUKOS Corp	Sale(S)	4,502	$124.65	$561,174	Direct
Jan 21, 2026	GKOS GLAUKOS Corp	Exercise(M)	4,502	$55.18	$248,420	Direct

1-25 of 46 transactions

About Gilliam Joseph E

Gilliam Joseph E (SEC CIK 0001705850) files insider reports with the SEC as Director of Caris Life Sciences, Inc. (CAI) and PRESIDENT & COO of GLAUKOS Corp (GKOS).

Signal8 holds 25 ownership filings by Gilliam Joseph E (1 Form 3, 24 Form 4), filed between Sep 23, 2024 and Aug 14, 2026. Those filings report 46 transactions, from Sep 19, 2024 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gilliam Joseph E's filings is in ALISO VIEJO, CA.

Recent filings by Gilliam Joseph E

Aug 14, 2026: Grant or award of CAI shares (Form 4, code A).
Aug 11, 2026: Open-market sales of GKOS shares (2 lines, Form 4, code S).
Aug 11, 2026: Option exercises of GKOS shares (4 lines, Form 4, code M).
Jun 25, 2026: Tax withholding of GKOS shares (Form 4, code F).
May 1, 2026: Open-market sale of GKOS shares (Form 4, code S).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes